• head_banner_01

OEM China Raw Material - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We support our buyers with ideal high quality products and high level service. Becoming the specialist manufacturer in this sector, we have gained rich practical experience in producing and managing for 2-(2-(4-Methylthiazol-5-Yl)Ethoxy)-2-Oxoethyl)Triphenylphosphonium Bromide, Potassium Chloride In Vaccines, Cmc Pseudouridine, Looking to the future, a long way to go, constantly striving to become the all staff with full enthusiasm, one hundred times the confidence and put our company built a beautiful environment, advanced products, quality first-class modern enterprise and work hard!
OEM China Raw Material - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:

Product Detail

NO.

Products

CAS No.

 Application

Key Quality Indicator

Purity

Isomer

SI *

Max *

Moisture

1

Fmoc-Lys(Mtt)-OH 167393-62-6 Lysine side chain modification

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤1.0%

2

Fmoc-Lys(Alloc)-OH 146982-27-6 Lysine side chain modification

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

3

Fmoc-Lys(ivDde)-OH 150629-67-7 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

Fmoc-Lys(Mmt)-OH 159857-60-0 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

5

Fmoc-Glu-OtBu 84793-07-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

6

Glu-OtBu 45120-30-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

7

Octadecanedioic acid 871-70-5 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

8

Octadecanedioic acid   mono-tert-butyl ester 843666-40-0 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

9

tBu-OOC-C16-CO-Glu-OtBu 1188328-39-3 SemaglutideFragment A

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

10

AEEA 134978-97-5 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

11

AEEA-OH.HCl 134979-01-4 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

12

Fmoc-AEEA-OH 166108-71-0 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

13

Boc-AEEA-OH 108466-89-3 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

14

AEEA-AEEA 1143516-05-5 Semaglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

15

Fmoc-AEEA-AEEA-OH 560088-89-3 SemaglutideFragment B

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

16

Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH 1118767-16-0 SemaglutideFragment C

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

17

tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu 1118767-15-9 SemaglutideFragment D

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

18

Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH 1662688-20-1 Semaglutide Fragment E

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

19

Boc-His(Trt)-OH 32926-43-5 The end is histidine

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤4.0%

20

Fmoc-Aib-OH 94744-50-0 Semaglutide

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

21

Boc-His(Trt)-Aib-OH 2061897-68-3 Semaglutide

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤2.0%

22

Fmoc-Glu(OtBu)-Gly-OH 866044-63-5 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

23

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH 1169630-31-2? Semaglutide Fragment F

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

24

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS 1169630-40-3 Semaglutide Fragment G

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

25

Fmoc-Arg(pbf)-Gly-OH 660846-80-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

26

Fmoc-Ala-Ala-OH 87512-31-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

27

Fmoc-Thr(tBu)-Phe-OH 1260609-75-3 ? GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

28

Palmitic acid 1957/10/3 Liraglutide Fragment 1

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

29

Palm-Glu-OtBu NA Liraglutide Fragment 2

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

30

Palm-Glu(NES)-OtBu NA Liraglutide Fragment 3

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

31

Fmoc-Lys(Palm-Glu-OtBu)-OH 1491158-62-3 Liraglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

32

Hexadecanedioic acid 505-54-4 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

33

Hexadecanedioic acid   mono-tert-butyl ester 843666-27-3 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

34

tBu-OOC-C14-CO-Glu-OtBu NA Insulin degludec Fragment I

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

35

tBu-OOC-C14-CO-Glu(NES)-OtBu NA Insulin degludec Fragment II

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

SI *= Specific Impurity

Max*= Max Unknown Impurity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

Sanitization

Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.


Product detail pictures:

OEM China Raw Material - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex detail pictures


Related Product Guide:

"Control the quality by the details, show the strength by quality". Our company has strived to establish a highly efficient and stable staff team and explored an effective quality control process for OEM China Raw Material - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: Adelaide, Vancouver, Slovak Republic, Our company, is always regarding quality as company' s foundation, seeking for development via high degree of credibility , abiding by iso9000 quality management standard strictly , creating top-ranking company by spirit of progress-marking honesty and optimism.
  • Production management mechanism is completed, quality is guaranteed, high credibility and service let the cooperation is easy, perfect!
    5 Stars By Lydia from Porto - 2017.12.31 14:53
    The company's products can meet our diverse needs, and the price is cheap, the most important is that the quality is also very nice.
    5 Stars By Fay from Jamaica - 2018.09.29 17:23
    Write your message here and send it to us